Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2023-02-21 17:15:43 UTC |
---|
HMDB ID | HMDB0001451 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | (R)-Lipoic acid |
---|
Description | Lipoic acid is a vitamin-like antioxidant that acts as a free-radical scavenger. Alpha-lipoic acid is also known as thioctic acid. It is a naturally occurring compound that is synthesized by both plants and animals. Lipoic acid contains two thiol groups which may be either oxidized or reduced. The reduced form is known as dihydrolipoic acid (DHLA). Lipoic acid (Delta E= -0.288) is therefore capable of thiol-disulfide exchange, giving it antioxidant activity. Lipoate is a critical cofactor for aerobic metabolism, participating in the transfer of acyl or methylamine groups via the 2-Oxoacid dehydrogenase (2-OADH) or alpha-ketoglutarate dehydrogenase complex. This enzyme catalyzes the conversion of alpha-ketoglutarate to succinyl CoA. This activity results in the catabolism of the branched chain amino acids (leucine, isoleucine and valine). Lipoic acid also participates in the glycine cleavage system(GCV). The glycine cleavage system is a multi-enzyme complex that catalyzes the oxidation of glycine to form 5,10 methylene tetrahydrofolate, an important cofactor in nucleic acid synthesis. Since Lipoic acid is an essential cofactor for many enzyme complexes, it is essential for aerobic life as we know it. This system is used by many organisms and plays a crucial role in the photosynthetic carbon cycle. Lipoic acid was first postulated to be an effective antioxidant when it was found it prevented vitamin C and vitamin E deficiency. It is able to scavenge reactive oxygen species and reduce other metabolites, such as glutathione or vitamins, maintaining a healthy cellular redox state. Lipoic acid has been shown in cell culture experiments to increase cellular uptake of glucose by recruiting the glucose transporter GLUT4 to the cell membrane, suggesting its use in diabetes. Studies of rat aging have suggested that the use of L-carnitine and lipoic acid results in improved memory performance and delayed structural mitochondrial decay. As a result, it may be helpful for people with Alzheimer's disease or Parkinson's disease. |
---|
Structure | InChI=1S/C8H14O2S2/c9-8(10)4-2-1-3-7-5-6-11-12-7/h7H,1-6H2,(H,9,10)/t7-/m1/s1 |
---|
Synonyms | Value | Source |
---|
(+)-alpha-Lipoic acid | ChEBI, HMDB | (R)-(+)-Lipoate | ChEBI, KEGG | (R)-(+)-Lipoic acid | ChEBI, Generator | (R)-1,2-Dithiolane-3-pentanoic acid | ChEBI, HMDB | (R)-1,2-Dithiolane-3-valeric acid | ChEBI, HMDB | (R)-6,8-Thioctic acid | ChEBI, HMDB | alpha-Lipoic acid | ChEBI, HMDB | Lipoic acid | ChEBI, HMDB | R-(+)-Lipoic acid | ChEBI, KEGG | R-LA | ChEBI, HMDB | RLA | ChEBI, HMDB | Thioctic acid | ChEBI, HMDB | Thioctic acid D-form | ChEBI, HMDB | (+)-a-Lipoate | Generator, HMDB | (+)-a-Lipoic acid | Generator, HMDB | (+)-alpha-Lipoate | Generator, HMDB | (+)-α-lipoate | Generator, HMDB | (+)-α-lipoic acid | Generator, HMDB | (R)-Lipoate | Generator | (R)-1,2-Dithiolane-3-pentanoate | Generator, HMDB | (R)-1,2-Dithiolane-3-valerate | Generator, HMDB | (R)-6,8-Thioctate | Generator, HMDB | a-Lipoate | Generator, HMDB | a-Lipoic acid | Generator, HMDB | alpha-Lipoate | Generator, HMDB | α-lipoate | Generator, HMDB | α-Lipoic acid | Generator, HMDB | Lipoate | Generator, HMDB | R-(+)-Lipoate | Generator | Thioctate | Generator, HMDB | Thioctate D-form | Generator, HMDB | Acid, alpha-lipoic | MeSH, HMDB | alpha Lipoic acid | MeSH, HMDB | 1,2-Dithiolane-3R-pentanoic acid | KEGG | 1,2-Dithiolane-3R-pentanoate | Generator | (R)-Lipoic acid | KEGG | (3R)-1,2-Dithiolane-3-pentanoic acid | HMDB | (R)-(+)-1,2-Dithiolane-3-pentanoic acid | HMDB | (R)-(+)-alpha-Lipoic acid | HMDB | (R)-(+)-α-Lipoic acid | HMDB | (R)-5-(1,2-Dithiolan-3-yl)pentanoicacid | HMDB | (R)-alpha-Lipoic acid | HMDB | (R)-α-Lipoic acid | HMDB | ALA | HMDB | alpha-(+)-Lipoic acid | HMDB | α-(+)-Lipoic acid | HMDB | 1,2-Dithiolane-3-valeric acid | HMDB | 5-(1,2-Dithiolan-3-yl)pentanoic acid | HMDB | 5-(1,2-Dithiolan-3-yl)valeric acid | HMDB | 6,8-Thioctic acid | HMDB | 6-Thioctic acid | HMDB |
|
---|
Chemical Formula | C8H14O2S2 |
---|
Average Molecular Weight | 206.326 |
---|
Monoisotopic Molecular Weight | 206.043521072 |
---|
IUPAC Name | 5-[(3R)-1,2-dithiolan-3-yl]pentanoic acid |
---|
Traditional Name | lipoic acid |
---|
CAS Registry Number | 1200-22-2 |
---|
SMILES | OC(=O)CCCC[C@@H]1CCSS1 |
---|
InChI Identifier | InChI=1S/C8H14O2S2/c9-8(10)4-2-1-3-7-5-6-11-12-7/h7H,1-6H2,(H,9,10)/t7-/m1/s1 |
---|
InChI Key | AGBQKNBQESQNJD-SSDOTTSWSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as lipoic acids and derivatives. Lipoic acids and derivatives are compounds containing a lipoic acid moiety (or a derivative thereof), which consists of a pentanoic acid (or derivative) attached to the C3 carbon atom of a 1,2-dithiolane ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Dithiolanes |
---|
Sub Class | Lipoic acids and derivatives |
---|
Direct Parent | Lipoic acids and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Lipoic_acid_derivative
- Medium-chain fatty acid
- Heterocyclic fatty acid
- Thia fatty acid
- Fatty acyl
- Fatty acid
- 1,2-dithiolane
- Organic disulfide
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Carboxylic acid derivative
- Hydrocarbon derivative
- Organooxygen compound
- Organic oxide
- Organic oxygen compound
- Carbonyl group
- Aliphatic heteromonocyclic compound
|
---|
Molecular Framework | Aliphatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 60.5 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatized |
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental GC-MS | GC-MS Spectrum - (R)-Lipoic acid GC-EI-TOF (Non-derivatized) | splash10-0aba-3900000000-46fc1d57abcc26f6720e | 2017-09-12 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - (R)-Lipoic acid GC-EI-TOF (Non-derivatized) | splash10-0aba-3900000000-46fc1d57abcc26f6720e | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - (R)-Lipoic acid GC-EI-TOF (Non-derivatized) | splash10-0aba-3900000000-46fc1d57abcc26f6720e | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Experimental GC-MS | GC-MS Spectrum - (R)-Lipoic acid GC-EI-TOF (Non-derivatized) | splash10-0aba-3900000000-46fc1d57abcc26f6720e | 2018-05-18 | HMDB team, MONA, MassBank | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - (R)-Lipoic acid GC-MS (Non-derivatized) - 70eV, Positive | splash10-0ufu-5900000000-716655e029db4b97efd9 | 2016-09-22 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - (R)-Lipoic acid GC-MS (1 TMS) - 70eV, Positive | splash10-0hbi-6920000000-011fb15a0f9ca4513029 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - (R)-Lipoic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - (R)-Lipoic acid Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-0a4r-0940000000-dead1b29e79e0002da2a | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - (R)-Lipoic acid Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-0f8c-9200000000-b6035bdb4abd0d267297 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - (R)-Lipoic acid Quattro_QQQ 40V, Positive-QTOF (Annotated) | splash10-0059-9000000000-62e73cabbac1531f5145 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - (R)-Lipoic acid 20V, Negative-QTOF | splash10-03di-9100000000-e420d2c931e889befcfa | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - (R)-Lipoic acid 10V, Negative-QTOF | splash10-0229-6900000000-90386d8704ab5bfe8e70 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - (R)-Lipoic acid 40V, Negative-QTOF | splash10-03di-9000000000-042d27906c9bde31821f | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - (R)-Lipoic acid 35V, Negative-QTOF | splash10-03di-9000000000-6572cec5a1c9f68d9679 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (R)-Lipoic acid 10V, Positive-QTOF | splash10-0a4r-0940000000-6cecd351951f396a3035 | 2016-09-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (R)-Lipoic acid 20V, Positive-QTOF | splash10-08gr-6910000000-f169816d57d2290b0d9e | 2016-09-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (R)-Lipoic acid 40V, Positive-QTOF | splash10-0m2c-9700000000-57ae386a681b98208a4b | 2016-09-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (R)-Lipoic acid 10V, Negative-QTOF | splash10-0a4i-1920000000-2b265e3ed116fbc0a2ea | 2016-09-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (R)-Lipoic acid 20V, Negative-QTOF | splash10-0ab9-2910000000-9142e84d978f4a481551 | 2016-09-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (R)-Lipoic acid 40V, Negative-QTOF | splash10-0a4i-9200000000-8bdfe1c35977a8c80985 | 2016-09-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (R)-Lipoic acid 10V, Positive-QTOF | splash10-0a4r-0970000000-0ae5b11a032d11c1ba6d | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (R)-Lipoic acid 20V, Positive-QTOF | splash10-03di-1900000000-decf255617c1bbd69bfb | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (R)-Lipoic acid 40V, Positive-QTOF | splash10-000i-6900000000-eb58a3d8135ba85d4283 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (R)-Lipoic acid 10V, Negative-QTOF | splash10-0a4i-0190000000-014d2ea36cfae0726a9e | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (R)-Lipoic acid 20V, Negative-QTOF | splash10-0a4i-5950000000-4e2dd5ccdcd5b0a936a0 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (R)-Lipoic acid 40V, Negative-QTOF | splash10-0a59-9500000000-9bbbd7b252fb9a0b438d | 2021-09-23 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | 2012-12-04 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | - Cytoplasm
- Extracellular
- Membrane (predicted from logP)
|
---|
Biospecimen Locations | |
---|
Tissue Locations | - Kidney
- Liver
- Neuron
- Placenta
- Skeletal Muscle
|
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Blood | Detected and Quantified | 0.077 +/- 0.017 uM | Adult (>18 years old) | Both | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Predicted Concentrations |
---|
| |
Blood | 0.000 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | Predicted based on drug qualities |
|
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB00166 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB022631 |
---|
KNApSAcK ID | C00000754 |
---|
Chemspider ID | 5886 |
---|
KEGG Compound ID | C16241 |
---|
BioCyc ID | LIPOIC-ACID |
---|
BiGG ID | 35801 |
---|
Wikipedia Link | Lipoic_acid |
---|
METLIN ID | 126 |
---|
PubChem Compound | 6112 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 30314 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | LIPOATE |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Download (PDF) |
---|
General References | - Teichert J, Tuemmers T, Achenbach H, Preiss C, Hermann R, Ruus P, Preiss R: Pharmacokinetics of alpha-lipoic acid in subjects with severe kidney damage and end-stage renal disease. J Clin Pharmacol. 2005 Mar;45(3):313-28. [PubMed:15703366 ]
- Arner ES, Nordberg J, Holmgren A: Efficient reduction of lipoamide and lipoic acid by mammalian thioredoxin reductase. Biochem Biophys Res Commun. 1996 Aug 5;225(1):268-74. [PubMed:8769129 ]
- Henriksen EJ, Saengsirisuwan V: Exercise training and antioxidants: relief from oxidative stress and insulin resistance. Exerc Sport Sci Rev. 2003 Apr;31(2):79-84. [PubMed:12715971 ]
- Loginov AS, Nilova TV, Bendikov EA, Petrakov AV: [Pharmacokinetics of preparations of lipoic acid and their effect on ATP synthesis, processes of microsomal and cytosol oxidation in hepatocytes in liver damage in man]. Farmakol Toksikol. 1989 Jul-Aug;52(4):78-82. [PubMed:2509239 ]
- Baker H, Deangelis B, Baker ER, Hutner SH: A practical assay of lipoate in biologic fluids and liver in health and disease. Free Radic Biol Med. 1998 Sep;25(4-5):473-9. [PubMed:9741583 ]
- Konrad D: Utilization of the insulin-signaling network in the metabolic actions of alpha-lipoic acid-reduction or oxidation? Antioxid Redox Signal. 2005 Jul-Aug;7(7-8):1032-9. [PubMed:15998258 ]
- Bruggraber SF, Leung PS, Amano K, Quan C, Kurth MJ, Nantz MH, Benson GD, Van de Water J, Luketic V, Roche TE, Ansari AA, Coppel RL, Gershwin ME: Autoreactivity to lipoate and a conjugated form of lipoate in primary biliary cirrhosis. Gastroenterology. 2003 Dec;125(6):1705-13. [PubMed:14724823 ]
- Redden PR, Melanson RL, Douglas JA, Dick AJ: Acyloxymethyl acidic drug derivatives: in vitro hydrolytic reactivity. Int J Pharm. 1999 Apr 15;180(2):151-60. [PubMed:10370185 ]
- Tankova T, Cherninkova S, Koev D: Treatment for diabetic mononeuropathy with alpha-lipoic acid. Int J Clin Pract. 2005 Jun;59(6):645-50. [PubMed:15924591 ]
- Chevion S, Hofmann M, Ziegler R, Chevion M, Nawroth PP: The antioxidant properties of thioctic acid: characterization by cyclic voltammetry. Biochem Mol Biol Int. 1997 Feb;41(2):317-27. [PubMed:9063572 ]
- Barbiroli B, Medori R, Tritschler HJ, Klopstock T, Seibel P, Reichmann H, Iotti S, Lodi R, Zaniol P: Lipoic (thioctic) acid increases brain energy availability and skeletal muscle performance as shown by in vivo 31P-MRS in a patient with mitochondrial cytopathy. J Neurol. 1995 Jul;242(7):472-7. [PubMed:7595680 ]
- Burke DG, Chilibeck PD, Parise G, Tarnopolsky MA, Candow DG: Effect of alpha-lipoic acid combined with creatine monohydrate on human skeletal muscle creatine and phosphagen concentration. Int J Sport Nutr Exerc Metab. 2003 Sep;13(3):294-302. [PubMed:14669930 ]
- Haj-Yehia AI, Assaf P, Nassar T, Katzhendler J: Determination of lipoic acid and dihydrolipoic acid in human plasma and urine by high-performance liquid chromatography with fluorimetric detection. J Chromatogr A. 2000 Feb 18;870(1-2):381-8. [PubMed:10722093 ]
- Nagamatsu M, Nickander KK, Schmelzer JD, Raya A, Wittrock DA, Tritschler H, Low PA: Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy. Diabetes Care. 1995 Aug;18(8):1160-7. [PubMed:7587852 ]
- Steinmann B, Gitzelmann R: Strychnine treatment attempted in newborn twins with severe nonketotic hyperglycinemia. Helv Paediatr Acta. 1979;34(6):589-99. [PubMed:541222 ]
- Lee WJ, Lee IK, Kim HS, Kim YM, Koh EH, Won JC, Han SM, Kim MS, Jo I, Oh GT, Park IS, Youn JH, Park SW, Lee KU, Park JY: Alpha-lipoic acid prevents endothelial dysfunction in obese rats via activation of AMP-activated protein kinase. Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2488-94. Epub 2005 Oct 13. [PubMed:16224049 ]
- McCormick DB: A trail of research on cofactors: an odyssey with friends. J Nutr. 2000 Feb;130(2S Suppl):323S-330S. [PubMed:10721897 ]
- Semenova TV, Azhitskii GIu, Sarnatskaia VV, Nikolaev VG: [Effect of various specific agents on the heat stability of human serum albumin]. Ukr Biokhim Zh (1978). 1993 Sep-Oct;65(5):26-30. [PubMed:8160293 ]
|
---|